Pulmonx Corporation (LUNG) ニュース

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the...

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the...

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Pulmonx meldet Behandlung des ersten Patienten mit dem AeriSeal®-System in der CONVERT-II-Zulassungsstudie

AeriSeal-System zeigt vielversprechende Ergebnisse bei der Begrenzung der kollateralen Ventilation, sodass mehr Patienten mit schwerer COPD bzw...

Pulmonx annonce le traitement du premier patient par système AeriSeal® dans l'essai pivot CONVERT II

Le système AeriSeal se montre prometteur dans la limitation de la ventilation collatérale, permettant potentiellement à un plus grand nombre de...

Pulmonx annuncia il trattamento del primo paziente con il sistema AeriSeal® nello studio pivotale CONVERT II

Il sistema AeriSeal si rivela promettente nel limitare la ventilazione collaterale, consentendo potenzialmente a un maggior numero di pazienti...

Form 4 - Statement of changes in beneficial ownership of securities